A nationally known, independent analyst, consultant and thought leader for the clinical
laboratory and anatomic pathology sectors for over three decades, Dennis is President
of Dennis Weissman & Associates, LLC, Falls Church, VA, a consultancy which
provides market intelligence, M&A advisory services, business leadership and public
policy advice to diagnostic and life science companies and organizations. Mr.
Weissman has expertise in Medicare and health care reform policies and trends;
clinical laboratory and pathology payment & compliance policies as well as business
trends affecting the diagnostic sector.
He currently advises BroadOak Capital Advisors, Bethesda, MD. an investment bank
with a comprehensive focus on the life sciences industry. In addition, he is on the
advisory board of Viewics, Inc., Sunnyvale, CA, an analytics platform for healthcare
organizations. In 1979, he founded and served as publisher of Washington G-2
Reports (now G2 Intelligence), an information company that reports on and analyzes
the U.S. clinical laboratory industry via newsletters, research reports and conferences
which was sold in 1999 to IOMA, a subsidiary of BNA.
Prior to G2, he served as the Director of the Washington Office of the American Society
for Medical Technology (now ASCLS) for five years and as Special Assistant to the
Deputy Assistant Secretary for Health, Department of Health, Education & Welfare (now
HHS) for two years.
Mr. Weissman holds a BA degree in political science from the State University of New
York at Buffalo and a MS degree in counseling and higher education administration
from Indiana University, Bloomington, IN.